Related Experiment Video
Updated: Jun 13, 2026
13:13
Biochemical Measurement of Neonatal Hypoxia
Published on: August 24, 2011
Persistent neonatal hypoglycemia: Diagnosis and management.
1Section of Clinical Genetics and Metabolism and Section of Neonatology, Department of Paediatrics and Child Health, University of Manitoba, Winnipeg, Manitoba.
Paediatrics & Child Health
|April 20, 2010
Summary
Neonatal hypoglycemia, low blood sugar in newborns, can stem from rare inborn errors of metabolism. This review details uncommon causes and diagnostic strategies for affected infants.
Area of Science:
- Biochemistry
- Pediatrics
- Endocrinology
Background:
- Plasma glucose regulation involves the endocrine system, enzyme function (glycogenolysis, gluconeogenesis), and substrate availability.
- Neonatal hypoglycemia is defined as serum glucose <2.2 mmol/L (first 72h) or <2.5 mmol/L (thereafter).
Purpose of the Study:
- To review uncommon causes of hypoglycemia in full-term, healthy neonates.
- To provide an investigative protocol for these conditions, including common diseases like hyperinsulinism.
Main Methods:
- Literature review focusing on inborn errors of metabolism and other rare causes.
- Development of a diagnostic protocol with rationale for test selection.
Main Results:
- Most uncommon causes of neonatal hypoglycemia are inborn errors of metabolism.
- A structured approach to investigation is crucial for timely diagnosis.
Conclusions:
- Early identification and management of rare metabolic disorders are vital for healthy neonatal outcomes.
- The proposed protocol aids in differentiating common from uncommon causes of neonatal hypoglycemia.
Related Concept Videos
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:20Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...